A citation-based method for searching scientific literature

Chang-Sheng Chang, Eiko Kitamura, Joan Johnson, Roni Bollag, Lesleyann Hawthorn. Genomics 2019
Times Cited: 13







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Triple-negative breast cancer in African-American women: disparities versus biology.
Eric C Dietze, Christopher Sistrunk, Gustavo Miranda-Carboni, Ruth O'Regan, Victoria L Seewaldt. Nat Rev Cancer 2015
240
30

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Tanya Keenan, Beverly Moy, Edmund A Mroz, Kenneth Ross, Andrzej Niemierko, James W Rocco, Steven Isakoff, Leif W Ellisen, Aditya Bardia. J Clin Oncol 2015
125
23

Differences in the tumor microenvironment between African-American and European-American breast cancer patients.
Damali N Martin, Brenda J Boersma, Ming Yi, Mark Reimers, Tiffany M Howe, Harry G Yfantis, Yien Che Tsai, Erica H Williams, Dong H Lee, Robert M Stephens,[...]. PLoS One 2009
147
23

African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study.
Azadeh Stark, Celina G Kleer, Iman Martin, Baffour Awuah, Anthony Nsiah-Asare, Valerie Takyi, Maria Braman, Solomon E Quayson, Richard Zarbo, Max Wicha,[...]. Cancer 2010
145
23

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Dezheng Huo, Hai Hu, Suhn K Rhie, Eric R Gamazon, Andrew D Cherniack, Jianfang Liu, Toshio F Yoshimatsu, Jason J Pitt, Katherine A Hoadley, Melissa Troester,[...]. JAMA Oncol 2017
144
15

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.
Masoud F Tavazoie, Ilana Pollack, Raissa Tanqueco, Benjamin N Ostendorf, Bernardo S Reis, Foster C Gonsalves, Isabel Kurth, Celia Andreu-Agullo, Mark L Derbyshire, Jessica Posada,[...]. Cell 2018
200
15

The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2018
15

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
Brian D Lehmann, Bojana Jovanović, Xi Chen, Monica V Estrada, Kimberly N Johnson, Yu Shyr, Harold L Moses, Melinda E Sanders, Jennifer A Pietenpol. PLoS One 2016
611
15

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
15

Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Jason J Pitt, Markus Riester, Yonglan Zheng, Toshio F Yoshimatsu, Ayodele Sanni, Olayiwola Oluwasola, Artur Veloso, Emma Labrot, Shengfeng Wang, Abayomi Odetunde,[...]. Nat Commun 2018
45
15

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
Carol E DeSantis, Stacey A Fedewa, Ann Goding Sauer, Joan L Kramer, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2016
794
15

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, Roberto Salgado, Carsten Denkert, Peter Savas, Susan Combs, David L Rimm, Jennifer M Giltnane, Monica V Estrada,[...]. Clin Cancer Res 2016
332
15

A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations.
Elvis Ofon, Harry Noyes, Julius Mulindwa, Hamidou Ilboudo, Martin Simuunza, Vincent Ebo'o, Flobert Njiokou, Mathurin Koffi, Bruno Bucheton, Pythagore Fogue,[...]. PLoS Negl Trop Dis 2017
13
15

Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.
Jessica M Grunda, Adam D Steg, Qinghua He, Mark R Steciuk, Suzanne Byan-Parker, Martin R Johnson, William E Grizzle. BMC Res Notes 2012
31
15

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.
Brittany D Jenkins, Rachel N Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W Howerth, Mary Egan, Jamie Hodgson, Clayton Yates,[...]. Cancer Epidemiol Biomarkers Prev 2019
21
15

Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
Kathleen Conway, Sharon N Edmiston, Chiu-Kit Tse, Christopher Bryant, Pei Fen Kuan, Brionna Y Hair, Eloise A Parrish, Ryan May, Theresa Swift-Scanlan. Cancer Epidemiol Biomarkers Prev 2015
29
15

Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.
Jyoti Mehrotra, M Michelle Ganpat, Yasmine Kanaan, Mary Jo Fackler, Megan McVeigh, Jaana Lahti-Domenici, Kornelia Polyak, Pedram Argani, Tammy Naab, Elizabeth Garrett,[...]. Clin Cancer Res 2004
84
15

GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma.
Manish Charan, Piyush Dravid, Maren Cam, Anthony Audino, Amy C Gross, Michael A Arnold, Ryan D Roberts, Timothy P Cripe, Alexander Pertsemlidis, Peter J Houghton,[...]. Int J Cancer 2020
27
15

ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.
Maren Cam, Manish Charan, Alessandra M Welker, Piyush Dravid, Adam W Studebaker, Jeffrey R Leonard, Christopher R Pierson, Ichiro Nakano, Christine E Beattie, Eugene I Hwang,[...]. Neuro Oncol 2020
17
15

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox,[...]. J Natl Cancer Inst 2018
153
15

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Mary Jo Lund, Katrina F Trivers, Peggy L Porter, Ralph J Coates, Brian Leyland-Jones, Otis W Brawley, Elaine W Flagg, Ruth M O'Regan, Sheryl G A Gabram, J William Eley. Breast Cancer Res Treat 2009
278
15

Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.
Matthew P Banegas, Li Tao, Sean Altekruse, William F Anderson, Esther M John, Christina A Clarke, Scarlett L Gomez. Breast Cancer Res Treat 2014
39
15

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
C Villarreal-Garza, J N Weitzel, M Llacuachaqui, E Sifuentes, M C Magallanes-Hoyos, L Gallardo, R M Alvarez-Gómez, J Herzog, D Castillo, R Royer,[...]. Breast Cancer Res Treat 2015
48
15

Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies.
Santiago Guerrero, Andrés López-Cortés, Alberto Indacochea, Jennyfer M García-Cárdenas, Ana Karina Zambrano, Alejandro Cabrera-Andrade, Patricia Guevara-Ramírez, Diana Abigail González, Paola E Leone, César Paz-Y-Miño. Sci Rep 2018
60
15

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Tara M Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Kwong, Edith Olah, Olufunmilayo I Olopade, Angela R Solano, Soo-Hwang Teo,[...]. Hum Mutat 2018
153
15



Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
15


Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women.
Shreya Prasad, Jimmy T Efird, Sarah E James, Paul R Walker, Timothy M Zagar, Tithi Biswas. Springerplus 2016
7
28


Racial differences in outcomes of triple-negative breast cancer.
Jose M Pacheco, Feng Gao, Caroline Bumb, Matthew J Ellis, Cynthia X Ma. Breast Cancer Res Treat 2013
28
15

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015
177
15

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.
Giampaolo Bianchini, Yuan Qi, Ricardo H Alvarez, Takayuki Iwamoto, Charles Coutant, Nuhad K Ibrahim, Vicente Valero, Massimo Cristofanilli, Marjorie C Green, Laszlo Radvanyi,[...]. J Clin Oncol 2010
155
7


Bringing the next Generation of Immuno-Oncology Biomarkers to the Clinic.
Alessandra Cesano, Sarah Warren. Biomedicines 2018
43
7

Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer.
Shivani S Shinde, Michele R Forman, Henry M Kuerer, Kai Yan, Florentia Peintinger, Kelly K Hunt, Gabriel N Hortobagyi, Lajos Pusztai, W Fraser Symmans. Cancer 2010
70
7

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, Sofie Ramskov, Rikke Lyngaa, Sunil Kumar Saini, Mariam Jamal-Hanjani, Gareth A Wilson, Nicolai J Birkbak, Crispin T Hiley,[...]. Science 2016
7

The cancer antigenome.
Bianca Heemskerk, Pia Kvistborg, Ton N M Schumacher. EMBO J 2013
174
7

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.
Diego Chowell, Luc G T Morris, Claud M Grigg, Jeffrey K Weber, Robert M Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M Kendall, David Requena, Nadeem Riaz,[...]. Science 2018
538
7

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy.
Mirjana Efremova, Francesca Finotello, Dietmar Rieder, Zlatko Trajanoski. Front Immunol 2017
112
7

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
Carsten Denkert, Sibylle Loibl, Aurelia Noske, Marc Roller, Berit Maria Müller, Martina Komor, Jan Budczies, Silvia Darb-Esfahani, Ralf Kronenwett, Claus Hanusch,[...]. J Clin Oncol 2010
7

The genomic landscape of breast cancer and its interaction with host immunity.
Stephen Luen, Balaji Virassamy, Peter Savas, Roberto Salgado, Sherene Loi. Breast 2016
139
7

Breast cancer statistics, 2013.
Carol DeSantis, Jiemin Ma, Leah Bryan, Ahmedin Jemal. CA Cancer J Clin 2014
7

Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Brigid K Killelea, Vicky Q Yang, Shi-Yi Wang, Brandon Hayse, Sarah Mougalian, Nina R Horowitz, Anees B Chagpar, Lajos Pusztai, Donald R Lannin. J Clin Oncol 2015
55
7

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.
Scott D Brown, Rene L Warren, Ewan A Gibb, Spencer D Martin, John J Spinelli, Brad H Nelson, Robert A Holt. Genome Res 2014
428
7


T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
Achim Rody, Uwe Holtrich, Laos Pusztai, Cornelia Liedtke, Regine Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, Andre Ahr, Dirk Metzler,[...]. Breast Cancer Res 2009
304
7

PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.
Hallie Wimberly, Jason R Brown, Kurt Schalper, Herbert Haack, Matthew R Silver, Christian Nixon, Veerle Bossuyt, Lajos Pusztai, Donald R Lannin, David L Rimm. Cancer Immunol Res 2015
257
7

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.